CAS: 1338259-05-4
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | SR 1664 REF: IN-DA01ENOGCAS: 1338259-05-4 | 97% | To inquire | Wed 27 Nov 24 |
 | SR1664 REF: TM-T23389CAS: 1338259-05-4 | 98.02% | 52.00 €~1,574.00 € | Wed 04 Dec 24 |
 | SR1664 REF: 3D-NDC25905CAS: 1338259-05-4 | Min. 95% | To inquire | Wed 08 Jan 25 |
Ref: IN-DA01ENOG
| 5mg | 220.00 € | ||
| 10mg | 520.00 € | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 27 Nov 2024
SR1664
CAS:1338259-05-4
SR1664 is a potent and selective PPARγ inhibitor with potential antidiabetic activity.
Formula:
C33H29N3O5
Purity:
98.02%
Color and Shape:
Solid
Molecular weight:
547.6
Ref: TM-T23389
| 1mg | 52.00 € | ||
| 2mg | 74.00 € | ||
| 5mg | 109.00 € | ||
| 10mg | 142.00 € | ||
| 25mg | 300.00 € | ||
| 50mg | 533.00 € | ||
| 100mg | 766.00 € | ||
| 500mg | 1,574.00 € | ||
| 1mL*10mM (DMSO) | 123.00 € |
Estimated delivery in United States, on Wednesday 4 Dec 2024
SR1664
CAS:1338259-05-4
SR1664 is a non-peptide, synthetic, small molecule that binds to the fatty acid binding site …
Formula:
C33H29N3O5
Purity:
Min. 95%
Molecular weight:
547.6 g/mol
Ref: 3D-NDC25905
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 8 Jan 2025
